Literature DB >> 10411041

The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.

M S Litwin1, M McNaughton-Collins, F J Fowler, J C Nickel, E A Calhoun, M A Pontari, R B Alexander, J T Farrar, M P O'Leary.   

Abstract

PURPOSE: Chronic abacterial prostatitis is a syndrome characterized by pelvic pain and voiding symptoms, which is poorly defined, poorly understood, poorly treated and bothersome. Research and clinical efforts to help men with this syndrome have been hampered by the absence of a widely accepted, reliable and valid instrument to measure symptoms and quality of life impact. We developed a psychometrically valid index of symptoms and quality of life impact for men with chronic prostatitis.
MATERIALS AND METHODS: We conducted a structured literature review of previous work to provide a foundation for the new instrument. We then conducted a series of focus groups comprising chronic prostatitis patients at 4 centers in North America, in which we identified the most important symptoms and effects of the condition. The results were used to create an initial draft of 55 questions that were used for formal cognitive testing on chronic prostatitis patients at the same centers. After expert panel review formal validation testing of a revised 21-item draft was performed in a diverse group of chronic prostatitis patients and 2 control groups of benign prostatic hyperplasia patients and healthy men. Based on this validation study, the index was finalized.
RESULTS: Analysis yielded an index of 9 items that address 3 different aspects of the chronic prostatitis experience. The primary component was pain, which we captured in 4 items focused on location, severity and frequency. Urinary function, another important component of symptoms, was captured in 2 items (1 irritative and 1 obstructive). Quality of life impact was captured with 3 items about the effect of symptoms on daily activities. The 9 items had high test-retest reliability (r = 0.83 to 0.93) and internal consistency (alpha = 0.86 to 0.91). All but the urinary items discriminated well between men with and without chronic prostatitis.
CONCLUSIONS: The National Institutes of Health chronic prostatitis symptom index provides a valid outcome measure for men with chronic prostatitis. The index is psychometrically robust, easily self-administered and highly discriminative. It was formally developed and psychometrically validated, and may be useful in clinical practice as well as research protocols.

Entities:  

Mesh:

Year:  1999        PMID: 10411041     DOI: 10.1016/s0022-5347(05)68562-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  229 in total

1.  Prostatitis: ancient history and new horizons.

Authors:  John N Krieger; Wolfgang Weidner
Journal:  World J Urol       Date:  2003-04-30       Impact factor: 4.226

2.  Prostatitis: diagnosis and classification.

Authors:  J Curtis Nickel
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 3.092

3.  Prostatitis.

Authors:  J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

4.  Ejaculatory duct dysfunction and lower urinary tract symptoms: chronic prostatitis.

Authors:  Matthew McIntyre; Harry Fisch
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

5.  Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Fei-Li Zhao; Ming Yue; Hua Yang; Tian Wang; Jiu-Hong Wu; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2010-06-24       Impact factor: 4.147

6.  Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.

Authors:  Michael J Barry; Sreelatha Meleth; Jeannette Y Lee; Karl J Kreder; Andrew L Avins; J Curtis Nickel; Claus G Roehrborn; E David Crawford; Harris E Foster; Steven A Kaplan; Andrew McCullough; Gerald L Andriole; Michael J Naslund; O Dale Williams; John W Kusek; Catherine M Meyers; Joseph M Betz; Alan Cantor; Kevin T McVary
Journal:  JAMA       Date:  2011-09-28       Impact factor: 56.272

7.  Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial.

Authors:  Yong Chen; Xiaohou Wu; Jia Liu; Wei Tang; Tao Zhao; Jianhua Zhang
Journal:  World J Urol       Date:  2010-03-25       Impact factor: 4.226

Review 8.  Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach.

Authors:  Jordan D Dimitrakov; Steven A Kaplan; Kurt Kroenke; Jeffrey L Jackson; Michael R Freeman
Journal:  Urology       Date:  2006-05       Impact factor: 2.649

9.  The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey.

Authors:  Jim C Hu; Carol L Link; Mary McNaughton-Collins; Michael J Barry; John B McKinlay
Journal:  J Gen Intern Med       Date:  2007-09-01       Impact factor: 5.128

10.  Lower urinary tract symptoms associated with prostatitis.

Authors:  J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.